Journal: Drug Invention Today

Article Id: JPRS-P col-00003469
Title: In silico and in vivo approach to identify the antidiabetic activity of lupeol
Category: Pharmacology
Section: Research Article
  • Abstract
  • Audio Abstract
  • Authors
  • Pdf File
  • Citation
  • My Reference
  • Methodology
  • Abstract

    Background: Diabetes mellitus (DM) is a metabolic disorder characterized by hyperglycemia. Many recent reports showed that there are 425 million people in the world suffering from diabetes and also, it has the chance to increase 629 million or more in 2045. Synthetic drugs used in the management of diabetes had many deleterious side effects. In this context, herbal drugs are attaining the attractiveness for the treatment of DM by reason of their efficacy, low occurrence of side effects, low cost, and easy availability. Lupeol (triterpenes) is one of the natural herbal drugs abundant in edible vegetables, fruits, and also in medicinal plants. It effectively reduced the hyperinsulinemia, blood glucose level in high cholesterol/high-fat diet, and sucrose-induced mice. However, the molecular mechanism by which it exhibits antidiabetic property is not known. Materials and Methods: Adult male albino rats of Wistar strain 150–180 days old with 180–120 g of body weight were randomly divided into four groups of six rats each. Group 1: Normal rats, Group 2: Type 2 diabetic rats, Group 3: Type 2 diabetic rats treated with lupeol 25 mg/kg for orally for 30 days, and Group 4: Type 2 diabetic rats treated with metformin 50 mg/kg orally for 30 days. Results: The effect of lupeol on insulin resistance protein expression in gracilis muscle of Type 2 diabetic rats showed a significant increase in P value (P < 0.05). The effects of glucose transporter 4 (GLUT 4) protein in gracilis muscle of Type 2 diabetic rats showed P < 0.05. Conclusion: Lupeol has antidiabetic activity through the regulation of insulin receptor and GLUT 4 protein expression in gracilis muscle, and hence, lupeol may be one of the potential therapeutic options for the management of Type 2 diabetics.

  • Abstract Audio

    No Audio file found

  • About the authors and Affiliations

    Author(s) Name:

    S. Shreenithi 1 , V. Vishnupriya1 , R. Ponnulakshmi 2 , R. Gayathri 1 , K. Madhan1 , B. Shyamaladevi 1 , J. Selvaraj1 *

    Affiliation(s) Name:

    1 Department of Biochemistry, Saveetha Dental College and Hospitals, Saveetha Institute of Medical and Technical Sciences, Saveetha University, Chennai, Tamil Nadu, India, 2 Department of Central Research Laboratory, Meenakshi Academy of Higher Education and Research, Chennai, Tamil Nadu, India *Corresponding author: Dr. J. Selvaraj, Department of Biochemistry, Saveetha Dental College and Hospitals, Saveetha Institute of Medical and Technical Sciences, Saveetha University, Chennai - 600 077, Tamil Nadu, India

  • View Article File in pdf format.

    Article File
  • View Article Citation Here.

    0 View More
  • How to Cite my Article.

    Author:

    S. Shreenithi 1 , V. Vishnupriya1 , R. Ponnulakshmi 2 , R. Gayathri 1 , K. Madhan1 , B. Shyamaladevi 1 , J. Selvaraj1 *

    Title:In silico and in vivo approach to identify the antidiabetic activity of lupeol
    Journal:Drug Invention Today
    Vol(issue):11 (May)
    Year:2019
    Page No: (1113-1116)
  • Experimental Methods Keywords

    Methodology:Antidiabetic activity, Diabetes mellitus
    Research Materials:Lupeol

Keywords

Antidiabetic activity Diabetes mellitus Lupeol

Our Services

Most Downloaded List